Method for detecting human papillomavirus mRNA
AssigneeNorchip A/S
InventorFrank Karlsen
Life of this patent
Estimating the term…
Abstract
An in vitro method is provided for screening human female subjects to assess their risk of developing cervical carcinoma which comprises screening the subject for expression of mRNA transcripts from the E6 and optionally the L1 gene of human papillomavirus, wherein subjects positive for expression of L1 and/or E6 mRNA are scored as being at risk of developing cervical carcinoma. Kits for carrying out such methods are also provided.
Claims15
An in vitro method of screening a human subject for the presence of integrated HPV or a modified episomal HPV genome, which method comprises specifically detecting, in a sample obtained from the human subject, expression of full length unspliced mRNA transcripts from the E6 gene of human papillomavirus wherein the splice variants E6*I, E6*II and E6*III are not detected, and wherein a subject positive for expression of full length unspliced E6 mRNA from at least one HPV type selected from the group consisting of HPV16, HPV18, HPV31, HPV33, HPV35, HPV45, HPV52 and HPV58 are scored as carrying integrated HPV or a modified episomal HPV genome.
An in vitro method of screening a human subject for the presence of integrated HPV or a modified episomal HPV genome, which method comprises specifically detecting, in a sample obtained from the human subject, expression of full length unspliced mRNA transcripts from the E6 gene of human papillomavirus using primers or probes specific for a region of the full length E6 mRNA transcript which is not present in the splice variants E6*I, E6*II and E6*III, and wherein a subject positive for expression of full length unspliced E6 mRNA from at least one HPV type selected from the group consisting of HPV16, HPV18, HPV31, HPV33, HPV35, HPV45, HPV52 and HPV58 are scored as carrying integrated HPV or a modified episomal HPV genome.
Dependencies are inferred from the claim text.